BrainsWay Ltd.(BWAY)Earnings, Financials & Key Ratios
BWAY•NASDAQ
$16.42
$322M mkt cap·45.6× P/E·Price updated May 6, 2026
AboutBrainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.Show more
- Revenue$53M+28.3%
- EBITDA$6M+86.8%
- Net Income$8M+163.4%
- EPS (Diluted)0.36+300.0%
- Gross Margin75.42%+1.1%
- EBITDA Margin11.22%+45.6%
- Operating Margin8.28%+144.1%
- Net Margin14.62%+105.2%
- ROE11.35%+101.9%
- ROIC61.2%+783.6%
- Debt/Equity0.09+3.2%
- Interest Coverage1.96+90.8%
BWAY Key Insights
BrainsWay Ltd. (BWAY) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong Piotroski F-Score: 7/9
- ✓FCF machine: 31.2% free cash flow margin
- ✓Momentum leader: RS Rating 94 (top 6%)
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 19.0%
✗Weaknesses
- ✗Weak 3Y average ROE of 2.4%
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
BWAY Price & Volume
BrainsWay Ltd. (BWAY) stock price & volume — 10-year historical chart
Loading chart...
BWAY Growth Metrics
BrainsWay Ltd. (BWAY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years22.71%
5 Years19%
3 Years24.65%
TTM27.55%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM161.94%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM139.23%
Return on Capital
10 Years-16.24%
5 Years-6.62%
3 Years-0.6%
Last Year5.13%
BWAY Recent Earnings
BrainsWay Ltd. (BWAY) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (82%)●Beat Revenue 6/12 qtrs (55%)
Q2 2026Latest
Mar 11, 2026EPS
$0.14
Est $0.06
+133.3%
Revenue
$15M
Est $14M
+3.8%
Q4 2025
Nov 11, 2025EPS
$0.08
Est $0.11
-27.3%
Revenue
$14M
Est $14M
-3.6%
Q4 2025
Sep 30, 2025EPS
$0.05
Revenue
$13M
Q2 2025
May 13, 2025EPS
$0.04
Est $0.02
+100.0%
Revenue
$12M
Est $12M
-5.2%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 11, 2026 | $0.14vs $0.06+133.3% | $15Mvs $14M+3.8% |
| Q4 2025 | Nov 11, 2025 | $0.08vs $0.11-27.3% | $14Mvs $14M-3.6% |
| Q4 2025 | Sep 30, 2025 | $0.05 | $13M |
| Q2 2025 | May 13, 2025 | $0.04vs $0.02+100.0% | $12Mvs $12M-5.2% |
Based on last 12 quarters of dataView full earnings history →
BWAY Peer Comparison
BrainsWay Ltd. (BWAY) competitors in Neuromodulation and neuro devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 STIM | 150.99M | 2.17 | -3.68 | 99.17% | -24.48% | -139.83% | 3.44 | |
 NVCR | 1.81B | 15.88 | -13.02 | 8.28% | -25.66% | -50.82% | 0.85 | |
 LIVN | 3.15B | 57.59 | -12.94 | 10.74% | -17.47% | -20.21% | 5.5% | 0.39 |
 GKOS | 7.81B | 133.42 | -40.68 | 32.33% | -34.34% | -26.46% | 0.21 | |
 ELMD | 213.7M | 25.81 | 30.01 | 16.97% | 13.06% | 19.79% | 5.19% | 0.00 |
 ABT | 151.59B | 87.18 | 11.41 | 4.59% | 31.88% | 27.26% | 4.19% | 0.32 |
 MDT | 99.73B | 77.79 | 21.55 | 3.62% | 13% | 9.45% | 5.2% | 0.59 |
 BSX | 83.2B | 55.98 | 28.86 | 19.87% | 14.4% | 12.4% | 4.4% | 0.51 |
Compare BWAY vs Peers
BrainsWay Ltd. (BWAY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
BWAY Income Statement
BrainsWay Ltd. (BWAY) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 11.14M | 16.4M | 23.1M | 22.06M | 29.66M | 27.18M | 31.79M | 41.02M | 52.64M |
| Revenue Growth % | -3.29% | 47.12% | 40.89% | -4.52% | 34.46% | -8.36% | 16.96% | 29.04% | 28.34% |
| Cost of Goods Sold | 2.6M | 3.59M | 5.13M | 5.06M | 6.6M | 7.13M | 8.31M | 10.44M | 12.94M |
| COGS % of Revenue | 23.28% | 21.89% | 22.2% | 22.93% | 22.25% | 26.23% | 26.14% | 25.44% | 24.58% |
| Gross Profit | 8.55M▲ 0% | 12.81M▲ 49.8% | 17.97M▲ 40.3% | 17M▼ 5.4% | 23.06M▲ 35.6% | 20.05M▼ 13.1% | 23.48M▲ 17.1% | 30.58M▲ 30.3% | 39.7M▲ 29.8% |
| Gross Margin % | 76.72% | 78.11% | 77.8% | 77.07% | 77.75% | 73.77% | 73.86% | 74.56% | 75.42% |
| Gross Profit Growth % | -6.01% | 49.8% | 40.32% | -5.41% | 35.64% | -13.05% | 17.1% | 30.26% | 29.81% |
| Operating Expenses | 15.16M | 17.92M | 26.45M | 21.83M | 28.06M | 32.73M | 28.44M | 29.19M | 35.34M |
| OpEx % of Revenue | 136.03% | 109.3% | 114.49% | 98.96% | 94.6% | 120.44% | 89.46% | 71.17% | 67.14% |
| Selling, General & Admin | 9.29M | 11.34M | 17.66M | 16M | 21.66M | 25.05M | 21.64M | 22M | 25.66M |
| SG&A % of Revenue | 83.4% | 69.15% | 76.43% | 72.56% | 73.05% | 92.18% | 68.08% | 53.64% | 48.75% |
| Research & Development | 5.34M | 6.16M | 7.88M | 5.82M | 6.39M | 7.68M | 6.67M | 7.19M | 9.68M |
| R&D % of Revenue | 47.94% | 37.54% | 34.09% | 26.4% | 21.56% | 28.25% | 20.97% | 17.53% | 18.39% |
| Other Operating Expenses | 523K | 427K | 916K | 0 | 0 | 0 | 133K | 0 | 0 |
| Operating Income | -6.61M▲ 0% | -5.11M▲ 22.6% | -8.48M▼ 65.7% | -4.83M▲ 43.0% | -5M▼ 3.5% | -12.68M▼ 153.7% | -4.96M▲ 60.9% | 1.39M▲ 128.1% | 4.36M▲ 213.2% |
| Operating Margin % | -59.32% | -31.19% | -36.69% | -21.89% | -16.86% | -46.67% | -15.6% | 3.39% | 8.28% |
| Operating Income Growth % | -219.53% | 22.64% | -65.74% | 43.03% | -3.52% | -153.71% | 60.9% | 128.05% | 213.25% |
| EBITDA | -5.54M | -3.89M | -5.68M | -3.21M | -3.31M | -11.15M | -3.62M | 3.16M | 5.91M |
| EBITDA Margin % | -49.7% | -23.7% | -24.59% | -14.56% | -11.17% | -41.02% | -11.4% | 7.71% | 11.22% |
| EBITDA Growth % | -290.07% | 29.84% | -46.19% | 43.48% | -3.18% | -236.52% | 67.51% | 187.3% | 86.83% |
| D&A (Non-Cash Add-back) | 1.07M | 1.23M | 2.79M | 1.62M | 1.69M | 1.53M | 1.34M | 1.77M | 1.55M |
| EBIT | -6.8M | -5.92M | -9.51M | -5.08M | -6.36M | -12.99M | -3.9M | 3.59M | 4.36M |
| Net Interest Income | -112K | -351K | -331K | -45K | 84K | 1.04M | 1.87M | 1.12M | 3.41M |
| Interest Income | 22K | 44K | 175K | 61K | 225K | 1.11M | 2.17M | 2.48M | 5.64M |
| Interest Expense | 134K | 395K | 506K | 106K | 141K | 68K | 298K | 1.36M | 2.23M |
| Other Income/Expense | -274K | -1.16M | -1.43M | -319K | -1.42M | -351K | 1.01M | 2.07M | 3.41M |
| Pretax Income | -6.88M▲ 0% | -6.27M▲ 8.9% | -9.91M▼ 58.0% | -5.15M▲ 48.0% | -6.42M▼ 24.7% | -13.03M▼ 103.1% | -3.95M▲ 69.7% | 3.46M▲ 187.7% | 7.77M▲ 124.7% |
| Pretax Margin % | -61.78% | -38.24% | -42.88% | -23.34% | -21.64% | -47.96% | -12.41% | 8.43% | 14.76% |
| Income Tax | 169K | 209K | 422K | 237K | 43K | 315K | 251K | 538K | 77.61K |
| Effective Tax Rate % | -2.45% | -3.33% | -4.26% | -4.6% | -0.67% | -2.42% | -6.36% | 15.55% | 1% |
| Net Income | -7.05M▲ 0% | -6.48M▲ 8.2% | -10.33M▼ 59.4% | -5.38M▲ 47.9% | -6.46M▼ 20.0% | -13.35M▼ 106.6% | -4.2M▲ 68.6% | 2.92M▲ 169.6% | 7.69M▲ 163.4% |
| Net Margin % | -63.29% | -39.51% | -44.71% | -24.41% | -21.79% | -49.12% | -13.2% | 7.12% | 14.62% |
| Net Income Growth % | -194.28% | 8.15% | -59.41% | 47.86% | -20% | -106.58% | 68.56% | 169.6% | 163.39% |
| Net Income (Continuing) | -7.05M | -6.48M | -10.33M | -5.38M | -6.46M | -13.35M | -4.2M | 2.92M | 7.69M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.48▲ 0% | -0.39▲ 18.7% | -0.50▼ 28.2% | -0.24▲ 52.0% | -0.21▲ 12.5% | -0.43▼ 104.8% | -0.13▲ 69.8% | 0.09▲ 169.2% | 0.36▲ 300.0% |
| EPS Growth % | -182.35% | 18.75% | -28.21% | 52% | 12.5% | -104.76% | 69.77% | 169.23% | 300% |
| EPS (Basic) | -0.48 | -0.39 | -0.50 | -0.24 | -0.21 | -0.43 | -0.13 | 0.09 | 0.40 |
| Diluted Shares Outstanding | 14.77M | 16.64M | 20.51M | 22.45M | 31.15M | 32.98M | 33.16M | 34.77M | 21.21M |
| Basic Shares Outstanding | 14.77M | 16.64M | 20.51M | 22.45M | 31.15M | 32.98M | 33.16M | 33.97M | 19.08M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
BWAY Balance Sheet
BrainsWay Ltd. (BWAY) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 17.89M | 13.48M | 28.83M | 24.3M | 65.45M | 58.09M | 55.47M | 79.67M | 84.89M |
| Cash & Short-Term Investments | 14.51M | 8.97M | 21.89M | 17.18M | 57.35M | 47.58M | 45.98M | 69.34M | 67.95M |
| Cash Only | 14.51M | 8.97M | 21.67M | 16.96M | 16.92M | 47.58M | 10.52M | 69.34M | 67.95M |
| Short-Term Investments | 0 | 0 | 221K | 221K | 40.43M | 0 | 35.47M | 0 | 0 |
| Accounts Receivable | 2.93M | 3.97M | 5.96M | 5.79M | 6.33M | 4.84M | 3.78M | 4.6M | 4.11M |
| Days Sales Outstanding | 95.83 | 88.46 | 94.11 | 95.81 | 77.93 | 65.06 | 43.41 | 40.9 | 28.51 |
| Inventory | 271K | 91K | 306K | 442K | 200K | 3.84M | 3.72M | 4.43M | 7.13M |
| Days Inventory Outstanding | 38.12 | 9.25 | 21.78 | 31.9 | 11.06 | 196.45 | 163.3 | 154.81 | 201.21 |
| Other Current Assets | 507K | 1.07M | 0 | 212K | 388K | 1.83M | 691K | 1.3M | 5.69M |
| Total Non-Current Assets | 9.14M | 10.12M | 9.91M | 9.71M | 10.29M | 6.39M | 7.51M | 14.65M | 28.03M |
| Property, Plant & Equipment | 7.09M | 7.63M | 15.23M | 9.55M | 9.33M | 5.35M | 5.79M | 11.95M | 12.17M |
| Fixed Asset Turnover | 1.57x | 2.15x | 1.52x | 2.31x | 3.18x | 5.08x | 5.49x | 3.43x | 4.33x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.34M |
| Other Non-Current Assets | 2.03M | 2.5M | -5.32M | 163K | 954K | 766K | 1.72M | 1.64M | 1.52M |
| Total Assets | 27.03M▲ 0% | 23.6M▼ 12.7% | 38.74M▲ 64.1% | 34.01M▼ 12.2% | 75.73M▲ 122.7% | 64.48M▼ 14.9% | 62.97M▼ 2.3% | 94.32M▲ 49.8% | 112.92M▲ 19.7% |
| Asset Turnover | 0.41x | 0.69x | 0.60x | 0.65x | 0.39x | 0.42x | 0.50x | 0.43x | 0.47x |
| Asset Growth % | 35.39% | -12.68% | 64.12% | -12.2% | 122.67% | -14.86% | -2.33% | 49.77% | 19.72% |
| Total Current Liabilities | 6.13M | 8.34M | 6.72M | 6.8M | 9.07M | 8.14M | 9.76M | 15.35M | 22.16M |
| Accounts Payable | 1.63M | 2.24M | 1.32M | 781K | 1.1M | 1.12M | 758K | 2.87M | 2.43M |
| Days Payables Outstanding | 229.41 | 228.11 | 93.94 | 56.36 | 60.95 | 57.14 | 33.3 | 100.32 | 68.48 |
| Short-Term Debt | 0 | 750K | 0 | 0 | 0 | 0 | 0 | 0 | 1.07M |
| Deferred Revenue (Current) | 2.45M | 1.33M | 1.3M | 1.54M | 2.19M | 1.48M | 0 | 5.73M | 10.55M |
| Other Current Liabilities | 2.88M | 2.12M | 1.93M | 1.68M | 2.12M | 2.92M | 4.07M | 2.72M | 8.11M |
| Current Ratio | 2.92x | 1.62x | 4.29x | 3.57x | 7.22x | 7.14x | 5.68x | 5.19x | 3.83x |
| Quick Ratio | 2.87x | 1.61x | 4.25x | 3.51x | 7.20x | 6.66x | 5.30x | 4.90x | 3.51x |
| Cash Conversion Cycle | -95.46 | -130.4 | 21.95 | 71.35 | 28.04 | 204.37 | 173.41 | 95.4 | 161.24 |
| Total Non-Current Liabilities | 8.18M | 8.31M | 7.8M | 7.58M | 9.34M | 10.94M | 11.63M | 16.66M | 12.5M |
| Long-Term Debt | 2.73M | 2.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 243K | 254K | 254K | 239K | 4.8M | 5.74M |
| Deferred Tax Liabilities | 112K | 140K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5.34M | 6.09M | 5.45M | 5.56M | 5.93M | 6.02M | 6.08M | 2.43M | 0 |
| Total Liabilities | 14.31M | 16.65M | 14.52M | 14.38M | 18.41M | 19.08M | 21.39M | 32M | 34.67M |
| Total Debt | 2.73M | 2.83M | 414K | 672K | 754K | 488K | 471K | 5.62M | 6.82M |
| Net Debt | -11.78M | -6.13M | -21.26M | -16.29M | -16.17M | -47.09M | -10.05M | -63.72M | -61.13M |
| Debt / Equity | 0.21x | 0.41x | 0.02x | 0.03x | 0.01x | 0.01x | 0.01x | 0.09x | 0.09x |
| Debt / EBITDA | - | - | - | - | - | - | - | 1.78x | 1.15x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | -20.15x | -10.35x |
| Interest Coverage | -49.34x | -12.95x | -16.75x | -45.56x | -35.45x | -186.51x | -16.64x | 1.03x | 1.96x |
| Total Equity | 12.72M▲ 0% | 6.95M▼ 45.4% | 24.22M▲ 248.4% | 19.63M▼ 18.9% | 57.33M▲ 192.0% | 45.4M▼ 20.8% | 41.58M▼ 8.4% | 62.31M▲ 49.9% | 73.22M▲ 17.5% |
| Equity Growth % | 23.66% | -45.35% | 248.39% | -18.93% | 191.97% | -20.81% | -8.41% | 49.86% | 17.5% |
| Book Value per Share | 0.86 | 0.42 | 1.18 | 0.87 | 1.84 | 1.38 | 1.25 | 1.79 | 3.45 |
| Total Shareholders' Equity | 12.72M | 6.95M | 24.22M | 19.63M | 57.33M | 45.4M | 41.58M | 62.31M | 73.22M |
| Common Stock | 171K | 171K | 233K | 233K | 363K | 364K | 367K | 413K | 429.99K |
| Retained Earnings | -55.1M | -61.58M | -71.91M | -77.29M | -83.76M | -97.11M | -101.3M | -98.38M | -90.75M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.27M | -2.19M | -2.19M | 1.56M | -2.19M | -2.19M | -2.19M | -2.19M | 1.32M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BWAY Cash Flow Statement
BrainsWay Ltd. (BWAY) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -3.47M | -3.77M | -7.24M | -1.44M | 884K | -9.76M | 1.28M | 10.3M | 18.16M |
| Operating CF Margin % | -31.11% | -23.01% | -31.36% | -6.51% | 2.98% | -35.91% | 4.04% | 25.11% | 34.5% |
| Operating CF Growth % | -44.34% | -8.83% | -92% | 80.18% | 161.56% | -1204.07% | 113.16% | 702.02% | 76.37% |
| Net Income | -7.05M | -6.48M | -10.33M | -5.38M | -6.46M | -13.35M | -4.2M | 2.92M | 7.69M |
| Depreciation & Amortization | 1.07M | 1.23M | 1.6M | 1.62M | 1.69M | 1.53M | 1.34M | 1.77M | 1.55M |
| Stock-Based Compensation | 1.03M | 710K | 1.26M | 799K | 1.89M | 1.47M | 381K | 1.42M | 0 |
| Deferred Taxes | 169K | 209K | 422K | 237K | 43K | 315K | 251K | 0 | 0 |
| Other Non-Cash Items | 230K | 763K | 1.95M | 1.12M | 2.66M | 1.72M | 1.88M | 1.8M | 1.27M |
| Working Capital Changes | 1.09M | -204K | -2.15M | 179K | 1.07M | -1.45M | 1.64M | 2.39M | 7.65M |
| Change in Receivables | -21K | -419K | -2.5M | -104K | -849K | 1.46M | 1.09M | -867K | 611.82K |
| Change in Inventory | 276K | -330K | 0 | 0 | -411K | -3.6M | -506K | -920K | -2M |
| Change in Payables | 310K | 859K | 175K | -552K | 289K | 0 | -327K | 2.12M | -480.78K |
| Cash from Investing | -2.45M | -1.14M | -2.45M | -2.46M | -42.22M | 42.17M | -37.41M | 30.31M | -17.63M |
| Capital Expenditures | -985K | -1.97M | -3.31M | -2.47M | -2.24M | 1.94M | -2.39M | -4.76M | -1.76M |
| CapEx % of Revenue | 8.84% | 12.03% | 14.33% | 11.2% | 7.55% | 7.12% | 7.51% | 11.62% | 3.35% |
| Acquisitions | 0 | 0 | 0 | 0 | 39.98M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -2M | 1.01M | 0 | 0 | -39.98M | 0 | -35.02M | 35.08M | 0 |
| Cash from Financing | 11.11M | -265K | 22.47M | -1.03M | 41.52M | -1.55M | -1.03M | 18.26M | -2.23M |
| Debt Issued (Net) | 2.7M | 0 | -3.43M | -417K | -475K | -533K | -271K | -424K | 0 |
| Equity Issued (Net) | 1000K | 0 | 1000K | 0 | 1000K | -52K | 0 | 1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -52K | 0 | 0 | 0 |
| Other Financing | -39K | -265K | -425K | -613K | -269K | -962K | -755K | 2.33M | -2.23M |
| Net Change in Cash | 5.33M▲ 0% | -5.54M▼ 203.9% | 12.71M▲ 329.3% | -4.71M▼ 137.1% | -40K▲ 99.2% | 30.66M▲ 76750.0% | -37.06M▼ 220.9% | 58.83M▲ 258.7% | -1.67M▼ 102.8% |
| Free Cash Flow | -4.45M▲ 0% | -5.75M▼ 29.0% | -10.55M▼ 83.7% | -3.91M▲ 63.0% | -1.35M▲ 65.3% | -9.76M▼ 620.8% | -1.1M▲ 88.7% | 6.5M▲ 689.7% | 16.4M▲ 152.2% |
| FCF Margin % | -39.95% | -35.04% | -45.69% | -17.71% | -4.57% | -35.91% | -3.47% | 15.86% | 31.16% |
| FCF Growth % | -58.43% | -29.04% | -83.73% | 62.99% | 65.34% | -620.83% | 88.7% | 689.66% | 152.18% |
| FCF per Share | -0.30 | -0.35 | -0.51 | -0.17 | -0.04 | -0.30 | -0.03 | 0.19 | 0.77 |
| FCF Conversion (FCF/Net Income) | 0.49x | 0.58x | 0.70x | 0.27x | -0.14x | 0.73x | -0.31x | 3.53x | 2.36x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 125K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BWAY Key Ratios
BrainsWay Ltd. (BWAY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -20.68% | -61.32% | -65.87% | -66.26% | -24.56% | -16.79% | -25.99% | -9.65% | 5.62% | 11.35% |
| Return on Invested Capital (ROIC) | -86.45% | -346.49% | -436.85% | -336.62% | -114.88% | -16.85% | -48.21% | -24.93% | 6.93% | 61.2% |
| Gross Margin | 78.94% | 76.72% | 78.11% | 77.8% | 77.07% | 77.75% | 73.77% | 73.86% | 74.56% | 75.42% |
| Net Margin | -20.8% | -63.29% | -39.51% | -44.71% | -24.41% | -21.79% | -49.12% | -13.2% | 7.12% | 14.62% |
| Debt / Equity | 0.08x | 0.21x | 0.41x | 0.02x | 0.03x | 0.01x | 0.01x | 0.01x | 0.09x | 0.09x |
| Interest Coverage | -33.92x | -49.34x | -12.95x | -16.75x | -45.56x | -35.45x | -186.51x | -16.64x | 1.03x | 1.96x |
| FCF Conversion | 1.00x | 0.49x | 0.58x | 0.70x | 0.27x | -0.14x | 0.73x | -0.31x | 3.53x | 2.36x |
| Revenue Growth | 69.47% | -3.29% | 47.12% | 40.89% | -4.52% | 34.46% | -8.36% | 16.96% | 29.04% | 28.34% |
BWAY Frequently Asked Questions
BrainsWay Ltd. (BWAY) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
BrainsWay Ltd. (BWAY) reported $52.3M in revenue for fiscal year 2025. This represents a 14263% increase from $0.4M in 2012.
BrainsWay Ltd. (BWAY) grew revenue by 28.3% over the past year. This is strong growth.
Yes, BrainsWay Ltd. (BWAY) is profitable, generating $7.7M in net income for fiscal year 2025 (14.6% net margin).
Dividend & Returns
BrainsWay Ltd. (BWAY) has a return on equity (ROE) of 11.4%. This is reasonable for most industries.
BrainsWay Ltd. (BWAY) generated $16.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More BWAY
BrainsWay Ltd. (BWAY) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates